Arcuate Nucleus NPY/AgRP Neurons

📖 Wiki Page

cell1047 wordssynced 2026-04-02

Arcuate Nucleus NPY/AgRP Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Arcuate Nucleus NPY/AgRP Neurons</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4072017](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4072017](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Paraventricular Nucleus (PVH)</td>
<td>NPY, AgRP, GABA</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamic Area (LHA)</td>
<td>NPY, GABA</td>
</tr>
<tr>
<td class="label">Parabrachial Nucleus</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Bed Nucleus of Stria Terminalis (BNST)</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Preoptic Area</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Dorsal Raphe Nucleus</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Ventral Tegmental Area</td>
<td>NPY</td>
</tr>
</table>

...

Arcuate Nucleus NPY/AgRP Neurons

Introduction

Arcuate Nucleus Npy Agrp Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Neuropeptide Y (NPY) and agouti-related peptide (AgRP) co-expressing neurons in the arcuate nucleus are the primary orexigenic (appetite-stimulating) neurons in the hypothalamus. They drive feeding behavior, regulate energy storage, and modulate stress responses. These neurons are central to energy homeostasis and have been increasingly recognized for their roles in neurodegenerative diseases[@luquet2005]. [@rodriguez2010]

Overview

[@ollmann1997]

[@tong2008]

[@de2012]

Taxonomy & Classification

External Database Links

[Cell Ontology (CL:4072017)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)
[OBO Foundry (CL:4072017)](http://purl.obolibrary.org/obo/CL_4072017)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

Morphology: agouti-related protein expressing neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

External Database Links

[Cell Ontology (CL:4072017)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)
[OBO Foundry (CL:4072017)](http://purl.obolibrary.org/obo/CL_4072017)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Neuroanatomy and Location

The arcuate nucleus (ARC) is located at the base of the hypothalamus, adjacent to the median eminence—a circumventricular organ with incomplete blood-brain barrier that allows peripheral metabolic signals to access ARC neurons[@rodriguez2010]. NPY/AgRP neurons constitute approximately 30-40% of neurons in the medial ARC and are strategically positioned to integrate hormonal and nutritional signals[@cowley1999].

Electrophysiological Properties

NPY/AgRP neurons exhibit unique electrophysiological characteristics:

Tonic activity: These neurons show persistent firing even in the absence of synaptic input, maintaining a depolarized resting membrane potential[@sternson2005]
Glucose sensitivity: Activated by low glucose levels through AMPK activation, and inhibited by high glucose[@fioramonti2007]
Ghrelin response: The hunger hormone ghrelin directly activates NPY/AgRP neurons via the growth hormone secretagogue receptor (GHSR)[@cowley2001]
Leptin inhibition: Leptin directly inhibits NPY/AgRP neurons through JAK-STAT signaling[@elias1999]
Population synchronization: NPY/AgRP neurons exhibit coordinated activity patterns that amplify feeding signals[@mandelblatcerf2017]

Projection Patterns

NPY/AgRP neurons project to multiple brain regions, forming a distributed network:

Molecular Signaling

Neuropeptide Y (NPY)

NPY is a 36-amino acid peptide belonging to the pancreatic polypeptide family. It acts through five G-protein-coupled receptors (Y1-Y5), with Y1 and Y5 mediating orexigenic effects[@pedrazzini2003]:

Y1 receptor: Primary mediator of NPY-induced feeding, expressed in PVH and LHA
Y5 receptor: Involved in feeding motivation and energy homeostasis
Y2 receptor: Autoreceptor on NPY terminals, modulates NPY release

AgRP is a 132-amino acid melanocortin antagonist that acts on melanocortin-3 and melanocortin-4 receptors (MC3R/MC4R) in the PVH, blocking α-MSH signaling and promoting feeding[@ollmann1997]. AgRP neurons co-release GABA, providing rapid synaptic inhibition of downstream targets[@tong2008].

NPY/AgRP in Neurodegeneration

Alzheimer's Disease

The metabolic dysfunction observed in Alzheimer's disease involves significant alterations in the NPY/AgRP system:

Type 3 Diabetes Hypothesis: Brain insulin resistance in the ARC contributes to AD pathogenesis, with NPY/AgRP neurons showing impaired insulin and IGF-1 signaling[@de2012]
Metabolic syndrome risk: Obesity and metabolic syndrome increase AD risk, partly through NPY system dysregulation
Amyloid interaction: NPY has been shown to affect amyloid precursor protein (APP) processing and Aβ toxicity in cellular models[@rose2011]
Neuroinflammation: AgRP may modulate microglial activation and neuroinflammatory responses
Appetite disturbances: Early dysregulated appetite and weight changes in AD correlate with ARC dysfunction
Leptin resistance: Common in both obesity and AD, linked to disease progression

Parkinson's Disease

Weight loss: Progressive weight loss in PD patients is associated with NPY system dysfunction[@bachmann2013]
Non-motor symptoms: Autonomic dysfunction in PD involves hypothalamic control systems including the ARC
Alpha-synuclein pathology: Evidence of α-synuclein accumulation in hypothalamic nuclei including the ARC[@rietdijk2017]
Melanocortin system: Dysregulation of melanocortin signaling contributes to metabolic symptoms in PD

Huntington's Disease

Early hyperphagia: Increased appetite and weight gain are early features of HD, linked to NPY/AgRP hyperactivity[@van2011]
Hypothalamic pathology: Post-mortem studies show NPY neuron loss in HD brains
Metabolic alterations: NPY system changes contribute to the characteristic metabolic phenotype of HD
Circadian disruption: NPY/AgRP rhythm alterations contribute to sleep and feeding disturbances

Amyotrophic Lateral Sclerosis (ALS)

Metabolic dysfunction: ALS patients often show hypermetabolism, linked to NPY system changes
Autonomic involvement: NPY/AgRP dysfunction may contribute to autonomic symptoms in ALS
Neuroprotection: NPY has demonstrated neuroprotective properties in some ALS models

Therapeutic Targets

NPY Receptor Antagonists

Y1 antagonists: BIBO3304 and Y1-selective compounds reduce food intake and may improve metabolic function[@turnbill2002]
Y5 antagonists: CGP-71683 and selective Y5 antagonists reduce feeding motivation

Ghrelin System Modulation

GHSR antagonists: Block ghrelin activation of NPY/AgRP neurons
GHSR inverse agonists: Reduce constitutive activity of ghrelin receptors

Metabolic Interventions

Leptin therapy: Being explored for hypothalamic dysfunction in neurodegeneration
AMPK modulators: Target metabolic sensing in NPY/AgRP neurons
GLP-1 agonists: Show promise for metabolic and neuroprotective effects

Melanocortin System

MC4R agonists: Melanotan II reduces food intake but has side effects
AgRP vaccination: Experimental approaches to neutralize AgRP

Background

The study of Arcuate Nucleus Npy Agrp Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

📖 View canonical wiki page →

Arcuate Nucleus NPY/AgRP Neurons

Arcuate Nucleus NPY/AgRP Neurons

Introduction

Arcuate Nucleus NPY/AgRP Neurons

Introduction

Overview

Taxonomy & Classification

External Database Links

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

External Database Links

Neuroanatomy and Location

Electrophysiological Properties

Projection Patterns

Molecular Signaling

Neuropeptide Y (NPY)

Agouti-Related Peptide (AgRP)

NPY/AgRP in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Targets

NPY Receptor Antagonists

Ghrelin System Modulation

Metabolic Interventions

Melanocortin System

Cross-Links

Background

External Links